We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DUK icon
176
Duke Energy
DUK
$96.2B
$124K 0.01%
1,380
– –
AJG icon
177
Arthur J. Gallagher & Co
AJG
$64.3B
$121K 0.01%
551
– –
FXH icon
178
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$118K 0.01%
1,090
– –
CW icon
179
Curtiss-Wright
CW
$27.6B
$118K 0.01%
640
– –
SLV icon
180
iShares Silver Trust
SLV
$29.9B
$115K 0.01%
5,525
– –
POST icon
181
Post Holdings
POST
$4.04B
$110K 0.01%
1,268
– –
FXO icon
182
First Trust Financials AlphaDEX Fund
FXO
$1.15B
$103K 0.01%
2,725
-1,870
-41% -$68.8K
TRV icon
183
Travelers Companies
TRV
$79.8B
$99.5K 0.01%
573
+325
+131% +$57.3K
CALY
184
Callaway Golf Company
CALY
$3.44B
$99.3K 0.01%
5,000
– –
AEE icon
185
Ameren
AEE
$30.2B
$98K 0.01%
1,200
– –
EFSC icon
186
Enterprise Financial Services Corp
EFSC
$2.42B
$96.2K 0.01%
2,460
– –
SEE
187
DELISTED
Sealed Air
SEE
$96K 0.01%
2,400
– –
IJR icon
188
iShares Core S&P Small-Cap ETF
IJR
$112B
$95.8K 0.01%
961
– –
BSCQ icon
189
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.64B
$92.7K 0.01%
4,895
-500
-9% -$9.55K
ADBE icon
190
Adobe
ADBE
$103B
$92.4K 0.01%
189
+24
+15% +$9.67K
EMN icon
191
Eastman Chemical
EMN
$8.39B
$92.1K 0.01%
1,100
– –
VZ icon
192
Verizon
VZ
$193B
$91.7K 0.01%
2,467
+467
+23% +$17.3K
AMT icon
193
American Tower
AMT
$78.3B
$90.4K 0.01%
466
+13
+3% +$2.54K
IWN icon
194
iShares Russell 2000 Value ETF
IWN
$14.6B
$90K 0.01%
639
+200
+46% +$27K
IWM icon
195
iShares Russell 2000 ETF
IWM
$82.5B
$89.9K 0.01%
+480
New +$85.6K
DFS
196
DELISTED
Discover Financial Services
DFS
$87.6K 0.01%
750
– –
EW icon
197
Edwards Lifesciences
EW
$51.2B
$86K 0.01%
912
– –
IVW icon
198
iShares S&P 500 Growth ETF
IVW
$77.1B
$84.6K 0.01%
1,200
– –
BP icon
199
BP
BP
$106B
$82.9K 0.01%
2,350
– –
EPC icon
200
Edgewell Personal Care
EPC
$1.35B
$82.6K 0.01%
2,000
– –
6 7
8
9 10

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.